Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$236.1M
+27.9% from 2023
Prescriptions
57K
$4,149.96 per claim
Patients
9,052
4,619 prescribers
Total spending, 2024
$236.1M
$26,081.74 per patient
Medicare prescription drug plans paid $236.1M for Actemra Actpen in 2024, for 56,894 prescriptions and refills to 9,052 patients (up 27.9% from 2023). The average cost per claim was $4,149.96.
New York had the highest Medicare cost for Actemra Actpen in 2024: $22.8M for 5,258 claims, followed by California ($20.6M).
Sebastian H Unizony, rheumatology in Boston, MA, had the highest Medicare cost for Actemra Actpen in 2024: 131 claims costing $766K.
Actemra Actpen is made by Roche Holding AG (ROG.SW), listed in the Medicare spending data as Genentech, Inc..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Sebastian H Unizony Boston, MA | Rheumatology | 131 | 22 | $766K |
| Mark A Matza Boston, MA | Rheumatology | 154 | 19 | $641K |
| Celine Ward Charleston, SC |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 3,325 | 32,702 | 5,483 | $126.5M |
| 2023 | 3,855 | 44,486 | 6,927 | $184.6M |
| 2024 | 4,619 | 56,894 | 9,052 | $236.1M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 125 |
| 19 |
| $615K |
| Alexandra Villa Forte Cleveland, OH | Rheumatology | 112 | 15 | $493K |
| Jeanne Gosselin Burlington, VT | Rheumatology | 104 | 18 | $445K |
| Mayra G Oberto-Medina Coon Rapids, MN | Internal Medicine | 84 | 13 | $443K |
| Hing-Sheung E Fung Waco, TX | Internal Medicine | 101 | 18 | $442K |
| Anne Marie Holly Rochester, NY | Physician Assistant | 96 | 23 | $440K |
| Omar Silvestre Oklahoma City, OK | Rheumatology | 113 | 17 | $438K |
| Ray H McLaughlin Jr. Tuscaloosa, AL | Rheumatology | 103 | 14 | $437K |
| Christy C Park Knoxville, TN | Rheumatology | 127 | 16 | $429K |
| Maria Thomas-John Dayton, OH | Rheumatology | 51 | Under 11 | $407K |
| Kevin W Byram Nashville, TN | Rheumatology | 92 | Under 11 | $406K |
| Mohamed Talaat Fishersville, VA | Rheumatology | 129 | 21 | $406K |
| Amanda L Matthews San Antonio, TX | Physician Assistant | 119 | 24 | $395K |
| Jeffry D Bieber Knoxville, TN | Rheumatology | 87 | 11 | $388K |
| Srikanth Naramala Visalia, CA | Rheumatology | 80 | 13 | $382K |
| Ilana Abeles Rochester, NY | Rheumatology | 64 | Under 11 | $381K |
| Belal Said Champaign, IL | Rheumatology | 66 | Under 11 | $381K |
| Muhammad Shamim Brownsville, TX | Internal Medicine | 81 | 12 | $380K |
| Carrie L Richardson Chicago, IL | Rheumatology | 79 | 13 | $368K |
| Amar Oza Orchard Park, NY | Rheumatology | 53 | 13 | $360K |
| Kayvan Kamali Longview, TX | Rheumatology | 82 | Under 11 | $356K |
| Jon Golenbiewski Winston Salem, NC | Rheumatology | 113 | 14 | $351K |
| Dennis Suarez Mayaguez, PR | Rheumatology | 87 | Under 11 | $349K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Genentech, Inc. ROG.SW | 56,900 | $236.1M |